Strategic positioning Targeted antibiotic therapy for periprosthetic joint infection positions ForCast Orthopedics to address a high-need, specialized market segment, presenting a compelling value proposition for hospital systems and orthopedic centers seeking improved outcomes and cost reduction.

Clinical leadership Founded by an experienced life sciences entrepreneur and leading orthopedic surgeon, the company leverages clinical credibility and physician leadership to accelerate adoption among surgeons and infection control teams.

Early-stage traction With funding of five million dollars and sub-$1 million annual revenue, there is an opportunity to engage early adopters, pilot programs, and key opinion leaders in major medical device and orthopedic groups to demonstrate value and scale uptake.

Strategic events Recent engagement at major orthopedic and medical device conferences (MTI, MDC, and related showcases) provides channel opportunities to connect with hospital procurement, spine and joint replacement programs, and distribution partners.

Competitive landscape Industry peers have large sales forces and revenues; ForCast can target incremental sales through hospital systems and multi-site health networks, offering a differentiated, localized infection therapy that complements or replaces less effective standard of care.